{"database": "lobbying", "table": "lobbying_activities", "rows": [[1621489, "a8b9295b-09c7-4898-b5aa-7306e2855783", "Q4", "THE DUBERSTEIN GROUP INC.", 12675, "PHRMA INC.", 2014, "fourth_quarter", "CPT", "Patent reform - HR 3309, Innovation Act; S 1720, Patent Transparency and Improvements Act of 2013; S 1013, Patent Abuse Reduction Act of 2013; S 866, Patent Quality Improvement Act of 2013.", "SENATE", 100000, null, 0, 0, "2015-01-15T10:20:02.107000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1621489"], "units": {}, "query_ms": 0.46490097884088755, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}